MedTrace Logo

Retrospective Study Assessing Molecular Features Predicting Response to Cetuximab

NCT00491140 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2008-10-01

No results posted yet for this study

Summary

The primary objective is to identify molecular features predicting response or resistance to cetuximab

Conditions

  • Colorectal Neoplasms

Interventions

GENETIC

Gene mutations analysis and FISH

FISH and mutation analysis of multiple genes

Sponsors & Collaborators

  • Istituto Clinico Humanitas

    lead OTHER

Principal Investigators

  • Armando Santoro, MD · Istituto Clinico Humanitas

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2007-05-31
Completion
2008-06-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00491140 on ClinicalTrials.gov